Effects of urotensin II in human arteries and veins of varying calibre

Chris Hillier, Colin Berry, Mark C. Petrie, Patrick J. O’Dwyer, Carlene Hamilton, Amanda Brown, John McMurray

Research output: Contribution to journalArticlepeer-review


Urotensin II (UII) is the ligand for the GPR14 receptor and the most potent vasoconstrictor in the cynomolgus monkey. UII also contracts rat thoracic aorta. We studied the effect of human UII (hUII) in human blood vessels. Small subcutaneous resistance arteries, internal mammary arteries, saphenous veins, and small subcutaneous veins were studied using standard techniques. Subcutaneous resistance arteries constricted in response to norepinephrine (maximum tension, 2.84±0.38 mN/mm; the concentration required to produce 50% of the maximum response [EC50], 0.52±0.07 µmol/L) and endothelin-1 (maximum tension, 4.19±0.93 mN/mm; EC50, 1.6±0.1 nmol/L). hUII did not contract these arteries, internal mammary arteries, or either type of vein, but it was a potent vasoconstrictor in rat thoracic aorta (maximum tension, 2.36±0.2 mN/mm; EC50, 1.13±0.36 nmol/L). hUII has no vasoconstrictor action in human arteries and veins of different sizes and vascular beds. Marked species differences in the actions of UII question its importance in human cardiovascular regulation.

Original languageEnglish
Pages (from-to)1378-1381
Number of pages4
Issue number10
Publication statusPublished - 1 Mar 2001


  • human arteries
  • human veins
  • urotensin II


Dive into the research topics of 'Effects of urotensin II in human arteries and veins of varying calibre'. Together they form a unique fingerprint.

Cite this